1. Home
  2. INFU vs EARN Comparison

INFU vs EARN Comparison

Compare INFU & EARN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INFU
  • EARN
  • Stock Information
  • Founded
  • INFU 2005
  • EARN 2012
  • Country
  • INFU United States
  • EARN United States
  • Employees
  • INFU N/A
  • EARN N/A
  • Industry
  • INFU Medical/Dental Instruments
  • EARN Real Estate Investment Trusts
  • Sector
  • INFU Health Care
  • EARN Real Estate
  • Exchange
  • INFU Nasdaq
  • EARN Nasdaq
  • Market Cap
  • INFU 189.2M
  • EARN 187.6M
  • IPO Year
  • INFU N/A
  • EARN 2013
  • Fundamental
  • Price
  • INFU $8.09
  • EARN $6.60
  • Analyst Decision
  • INFU
  • EARN Hold
  • Analyst Count
  • INFU 0
  • EARN 1
  • Target Price
  • INFU N/A
  • EARN N/A
  • AVG Volume (30 Days)
  • INFU 85.2K
  • EARN 639.2K
  • Earning Date
  • INFU 03-13-2025
  • EARN 03-05-2025
  • Dividend Yield
  • INFU N/A
  • EARN 14.53%
  • EPS Growth
  • INFU 60.96
  • EARN 277.67
  • EPS
  • INFU 0.07
  • EARN 1.02
  • Revenue
  • INFU $132,783,999.00
  • EARN N/A
  • Revenue This Year
  • INFU $10.23
  • EARN N/A
  • Revenue Next Year
  • INFU $8.80
  • EARN $89.08
  • P/E Ratio
  • INFU $115.42
  • EARN $6.46
  • Revenue Growth
  • INFU 8.17
  • EARN N/A
  • 52 Week Low
  • INFU $5.74
  • EARN $5.54
  • 52 Week High
  • INFU $9.97
  • EARN $7.26
  • Technical
  • Relative Strength Index (RSI)
  • INFU 46.37
  • EARN 48.80
  • Support Level
  • INFU $7.99
  • EARN $6.53
  • Resistance Level
  • INFU $8.56
  • EARN $6.82
  • Average True Range (ATR)
  • INFU 0.26
  • EARN 0.13
  • MACD
  • INFU 0.02
  • EARN 0.00
  • Stochastic Oscillator
  • INFU 40.91
  • EARN 40.26

About INFU InfuSystems Holdings Inc.

InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair.

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on strong risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times of stress. It also leverages Ellington's proprietary technology, analytics and risk management systems to enhance underwriting and investment selection and to guide ongoing portfolio monitoring and surveillance.

Share on Social Networks: